A New Generation of Anti-viral Vaccines for Aquaculture Using Nanotechnology

Award Information
Agency: Department of Commerce
Branch: N/A
Contract: DG133R-03-CN-0054
Agency Tracking Number: 2003-70
Amount: $49,820.00
Phase: Phase I
Program: SBIR
Awards Year: 2003
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Profishent, Inc.
17806 N.E. 26th Street, Redmond, WA, 98052
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 David Powell
 Vice President
 (425) 881-9244
Business Contact
 Roger Palm
Title: President
Phone: (206) 322-8362
Email: rogerp@profishent.com
Research Institution
This innovative Phase 1 project will test the feasibility of using the science of nanotechnology and emulsion chemistry to produce nanoparticles in a matrix to greatly enhance the immunogenicity of inactivated viruses. This new approach promises to have direct application to the development of potent cost-effective anti-viral vaccines for aquatic animals. These novel formulations should stimulate protective humoral and cellular immune responses by targeting antigen presenting cells. Infectious hematopoietic necrosis virus (IHNV) and infectious salmon anemia virus (ISAV) will be used as model organisms to assess the binding and initial potency of these complex viral carriers. Emphasis will be placed on creating nanoparticles with high affinities to viral particles, followed by a comparison of antibody response kinetics and possible side effects in rainbow trout

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government